NCT06950528Completed
Monocular-Camera-Based Mobile Exergame for Type 2 Diabetes Prevention
Development and Evaluation of a Monocular-Camera-Based Mobile Exergame for At-Home Intervention in Individuals at High Risk of Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 30 Apr 2025
Brief summary (registry, in English)
Exergames have demonstrated potential as effective interventions for promoting physical activity and preventing type 2 diabetes (T2D), particularly among older adults. Kinect-based exergames, in particular, have been associated with improved adherence to exercise regimens and positive health outcomes. However, widespread implementation is limited by the high cost and reduced accessibility of the required hardware, restricting their use in home-based settings. Recent advances in computer vision have enabled the development of exergames using monocular camera systems, which may represent a cost-effective and scalable alternative. This study investigates the feasibility of monocular-camera-based exergames as a cost-effective and convenient alternative for home-dwelling individuals. A total of 45 community-dwelling older adults aged 60-74 years, identified as high risk for T2D were recruited through local community health centers. Participants were randomly assigned to one of three groups (n = 15 per group): (1) Control group (traditional offline exercise with printed instructions), (2) Kinect group (Kinect-based exergames targeting aerobic capacity, balance, and strength), and (3) Monocular group (monocular-camera-based exergames using real-time 2D pose estimation). The intervention lasted six weeks, with participants completing three 30-minute sessions per week at home. Primary outcomes included exercise performance (completion rate and movement accuracy) and intrinsic motivation. Secondary outcomes included perceived enjoyment, challenge, and usability. Data were analyzed using one-way ANOVA.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 45 (actual)
- First submitted
- 10 Apr 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Diseases
- Type 2 diabetes
- NCT number
- NCT06950528
What you commit to
- Study type: Interventional
- Participants enrolled: 45
- From 1 Jan 2024 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- major mobility limitations such as severe osteoarthritis and recent orthopedic surgery.
Other illness
- diagnosis of type 1 or type 2 diabetes;
- severe cognitive impairment with MMSE \< 24;
Other
- current participation in another exercise intervention study;
Who the study is looking for
- age between 60-74;
- a score of 25 or higher on the Chinese Diabetes Risk Score;
- community-dwelling individuals, not reside in assisted living or long-term care facilities;
- physically capable of engaging in light to moderate exercise, as determined by self-report and/or physician clearance;
- normal cognitive function that enable the participant to complete the experiment independently or with minimal assistance;
- Written informed consent provided by participants or their families.
Age in the registry: 60 years to 74 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hongqiao Community Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.